RNASEH2B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.859800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.293200E-01
Normal-vs-Stage2
5.260100E-03
Normal-vs-Stage3
1.074640E-01
Normal-vs-Stage4
1.085760E-01
Stage1-vs-Stage2
7.099800E-01
Stage1-vs-Stage3
5.615000E-01
Stage1-vs-Stage4
8.108400E-01
Stage2-vs-Stage3
3.791600E-01
Stage2-vs-Stage4
7.811000E-01
Stage3-vs-Stage4
6.606600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.015500E-03
Normal-vs-AfricanAmerican
8.957800E-02
Normal-vs-Asian
4.062200E-02
Caucasian-vs-AfricanAmerican
7.851600E-01
Caucasian-vs-Asian
9.290600E-01
AfricanAmerican-vs-Asian
8.551800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.715200E-03
Normal-vs-Female
6.318200E-03
Male-vs-Female
9.102400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.361200E-01
Normal-vs-Age(41-60Yrs)
2.592200E-01
Normal-vs-Age(61-80Yrs)
7.481000E-03
Normal-vs-Age(81-100Yrs)
3.052800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.961400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.338800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.089400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.471600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.672400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.968200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.135500E-03
Normal-vs-Daily Drinker
8.435300E-03
Normal-vs-Weekly Drinker
2.035600E-02
Normal-vs-Occasional Drinker
1.031650E-02
Normal-vs-Social Drinker
2.107900E-02
Non Drinker-vs-Daily Drinker
9.999200E-01
Non Drinker-vs-Weekly Drinker
4.745200E-01
Non Drinker-vs-Occasional Drinker
9.532000E-01
Non Drinker-vs-Social Drinker
3.872000E-01
Daily Drinker-vs-Weekly Drinker
4.791600E-01
Daily Drinker-vs-Occasional Drinker
9.544800E-01
Daily Drinker-vs-Social Drinker
3.937600E-01
Weekly Drinker-vs-Occasional Drinker
5.177000E-01
Weekly Drinker-vs-Social Drinker
8.955800E-01
Occasional Drinker-vs-Social Drinker
4.310000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.304000E-01
Normal-vs-Grade 2
8.076400E-01
Normal-vs-Grade 3
8.704800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.854000E-01
Grade 1-vs-Grade 3
3.403200E-01
Grade 1-vs-Grade 4
5.304000E-01
Grade 2-vs-Grade 3
2.135000E-01
Grade 2-vs-Grade 4
8.076400E-01
Grade 3-vs-Grade 4
8.704800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.983200E-03
Normal-vs-NonDiabetic
2.855200E-03
Diabetic-vs-NonDiabetic
5.922400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.686300E-02
Normal-vs-NoPancreatitis
2.324300E-03
Pancreatitis-vs-NoPancreatitis
5.296400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.961400E-03
Normal-vs-N1
5.116800E-03
N0-vs-N1
8.397200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.633000E-01
Normal-vs-TP53-NonMutant
3.341500E-02
TP53-Mutant-vs-TP53-NonMutant
7.997800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
